Category: Events

Experience firsthand insights from company CEOs, secure direct access to high-quality investments and join a sophisticated network of successful investors.

Filter Events by Categories

  • Company Q&A’s
  • Events
  • Upcoming Events
  • Webcast
  • ASX Company Webcasts
  • Meet the CEO’s
  • Meet The Manager
  • Reach Shortz
  • Summits
  • The Insider
  • Test2

Upcoming Events

Plutonic – Live Investor Briefing

Friday, 7th June 1pm (AEST)

Live Investor Briefing

Please join Plutonic Non-Executive Chairman Hedley Widdup for an investor briefing. In this session, Hedley will discuss why he thinks their flagship project could define a new mining district rivalling the biggest copper-gold projects in the world.

Speaker

Joseph Webb Executive Director

5th June 2026

5th March 2026

Register for upcoming events

Live Investor Briefing

Speaker

Company Q&A’s

5th June 2026

5th July 2026

Q&A with Joyned founders Jonathan Abraham and Michael Levinson

29th May 2024

Live Investor Briefing

Joyned is an E-commerce technology company that is revolutionising how online purchases are made. Partnered with €31 B travel giant Amadeus, the business is rolling out its solution, targeting the $2.3 trillion-dollar global tourism industry.

Speaker

DR Gerard Dyson

Managing Director – Spectur Limited (ASX: SP3)

5th June 2026

5th July 2026

Q&A with Institutional Investor – John Forwood

29th May 2024

Live Investor Briefing

John Forwood, CIO of Lowell Resources Fund, discusses his ‘blue-sky’ thesis for Plutonic and compares it to previous portfolio winners.

Speaker

DR Gerard Dyson

Managing Director – Spectur Limited (ASX: SP3)

5th June 2026

5th July 2026

Xsights Q&A with Steve Wildisen

29th May 2024

Live Investor Briefing

Hedley Widdup, CEO of leading resources fund manager Lion Selection Group (ASX:LSX), discusses why he believes that Plutonic represents a “once in a cycle” opportunity, elaborating on their progress and pathway to IPO.

Speaker

DR Gerard Dyson

Managing Director – Spectur Limited (ASX: SP3)

5th June 2026

5th July 2026

Q&A on Plutonic with Hedley Widdup

29th May 2024

Live Investor Briefing

Hedley Widdup, CEO of leading resources fund manager Lion Selection Group (ASX:LSX), discusses why he believes that Plutonic represents a “once in a cycle” opportunity, elaborating on their progress and pathway to IPO.

Speaker

DR Gerard Dyson

Managing Director – Spectur Limited (ASX: SP3)

5th June 2026

5th July 2026

Q&A on Plutonic with Dr Kris Butera

29th May 2024

Live Investor Briefing

Plutonic founder Dr Kris Butera discusses his flagship Champion project, expanding on why he believes there is potential for a resource deposit that is “unlike anything he has ever seen.”

Speaker

DR Gerard Dyson

Managing Director – Spectur Limited (ASX: SP3)

Prescient Therapeutics (ASX: PTX) Q&A Investor Update

25th March 2024

Live Investor Briefing

In this session Prescient CEO and Managing Director Steven Yatomi-Clarke provide a company update on strategy and upcoming milestones.

Speaker

DR Gerard Dyson

Managing Director – Spectur Limited (ASX: SP3)

Wellnex Life (ASX: WNX) Webcast Replay

15th February 2024

Live Investor Briefing

In this session Wellnex Life MD Zack Bozinovski and Non-Executive Chairman Mario Tascone discussed what attracted Mario to Wellnex and where he sees the future of the business;

Speaker

DR Gerard Dyson

Managing Director – Spectur Limited (ASX: SP3)

Wellnex Life (ASX: WNX) Webcast Replay

15th February 2024

Live Investor Briefing

In this session Wellnex Life MD Zack Bozinovski and Non-Executive Chairman Mario Tascone discussed what attracted Mario to Wellnex and where he sees the future of the business;

Speaker

DR Gerard Dyson

Managing Director – Spectur Limited (ASX: SP3)

5th June 2026

5th February 2026

Q&A with Joyned founders Jonathan Abraham and Michael Levinson

29th May 2024

Live Investor Briefing

Joyned is an E-commerce technology company that is revolutionising how online purchases are made. Partnered with €31 B travel giant Amadeus, the business is rolling out its solution, targeting the $2.3 trillion-dollar global tourism industry.

Speaker

DR Gerard Dyson

Managing Director – Spectur Limited (ASX: SP3)

5th June 2026

5th February 2026

Q&A with Joyned founders Jonathan Abraham and Michael Levinson

29th May 2024

Live Investor Briefing

Joyned is an E-commerce technology company that is revolutionising how online purchases are made. Partnered with €31 B travel giant Amadeus, the business is rolling out its solution, targeting the $2.3 trillion-dollar global tourism industry.

Speaker

DR Gerard Dyson

Managing Director – Spectur Limited (ASX: SP3)

5th June 2026

5th February 2026

Q&A with Joyned founders Jonathan Abraham and Michael Levinson

29th May 2024

Live Investor Briefing

Joyned is an E-commerce technology company that is revolutionising how online purchases are made. Partnered with €31 B travel giant Amadeus, the business is rolling out its solution, targeting the $2.3 trillion-dollar global tourism industry.

Speaker

DR Gerard Dyson

Managing Director – Spectur Limited (ASX: SP3)

5th June 2026

5th February 2026

Q&A with Joyned founders Jonathan Abraham and Michael Levinson

29th May 2024

Live Investor Briefing

Joyned is an E-commerce technology company that is revolutionising how online purchases are made. Partnered with €31 B travel giant Amadeus, the business is rolling out its solution, targeting the $2.3 trillion-dollar global tourism industry.

Speaker

DR Gerard Dyson

Managing Director – Spectur Limited (ASX: SP3)

Reach Shortz

5th June 2026

5th May 2026

Felix Gold (ASX: FXG) Webcast Replay

16th May 2024

Live Investor Briefing

In this session Felix Gold Executive Director Joseph Webb discussed their plans to develop a potential multi million ounce high grade gold resource.

Speaker

DR Gerard Dyson Managing Director – Spectur Limited (ASX: SP3)

Summits

5th June 2026

5th May 2026

Felix Gold (ASX: FXG) Webcast Replay

16th May 2024

Live Investor Briefing

In this session Felix Gold Executive Director Joseph Webb discussed their plans to develop a potential multi million ounce high grade gold resource.

Speaker

DR Gerard Dyson Managing Director – Spectur Limited (ASX: SP3)

The Insider

5th June 2026

5th May 2026

Felix Gold (ASX: FXG) Webcast Replay

16th May 2024

Live Investor Briefing

In this session Felix Gold Executive Director Joseph Webb discussed their plans to develop a potential multi million ounce high grade gold resource.

Speaker

DR Gerard Dyson Managing Director – Spectur Limited (ASX: SP3)

Webcast

Q&A on Plutonic with Dr Kris Butera

29th May 2024

Live Investor Briefing

Plutonic founder Dr Kris Butera discusses his flagship Champion project, expanding on why he believes there is potential for a resource deposit that is “unlike anything he has ever seen.”

Speaker

DR Gerard Dyson

Managing Director – Spectur Limited (ASX: SP3)

5th June 2026

5th May 2026

Felix Gold (ASX: FXG) Webcast Replay

16th May 2024

Live Investor Briefing

In this session Felix Gold Executive Director Joseph Webb discussed their plans to develop a potential multi million ounce high grade gold resource.

Speaker

DR Gerard Dyson Managing Director – Spectur Limited (ASX: SP3)

Far East Gold (ASX: FEG) Webcast Replay

18th April 2024

Live Investor Briefing

In this session Far East Gold’s CEO and Director Shane Menere discussed the standout assays from our Woyla drilling campaigns that form the base of our upcoming maiden JORC resource publication.

Speaker

DR Gerard Dyson Managing Director – Spectur Limited (ASX: SP3)

Prescient Therapeutics (ASX: PTX) Webcast Replay

9th April 2024

Live Investor Briefing

In this session Prescient CEO and Managing Director Steven Yatomi-Clarke discussed why the data from their PTX-100 Phase 1b trial is so promising.

Speaker

DR Gerard Dyson Managing Director – Spectur Limited (ASX: SP3)

Prescient Therapeutics (ASX: PTX) Q&A Investor Update

25th March 2024

Live Investor Briefing

In this session Prescient CEO and Managing Director Steven Yatomi-Clarke provide a company update on strategy and upcoming milestones.

Speaker

DR Gerard Dyson

Managing Director – Spectur Limited (ASX: SP3)

Pitt Street Research on Prescient Therapeutics

14th March 2024

Live Investor Briefing

Join Stuart Roberts, co-founder and senior analyst at Pitt Street Research, for an online briefing where he will outline the recent Pitt Street Research report on Prescient Therapeutics.

Speaker

DR Gerard Dyson Managing Director – Spectur Limited (ASX: SP3)

Far East Gold (ASX: FEG) Webcast Replay

22nd February 2024

Live Investor Briefing

In this session Far East Gold’s CEO and Director Shane Menere discussed, why the Board (including Nickel Industries MD Justin Werner) is optimistic about the findings so far……

Speaker

DR Gerard Dyson Managing Director – Spectur Limited (ASX: SP3)

Wellnex Life (ASX: WNX) Webcast Replay

15th February 2024

Live Investor Briefing

In this session Wellnex Life MD Zack Bozinovski and Non-Executive Chairman Mario Tascone discussed what attracted Mario to Wellnex and where he sees the future of the business;

Speaker

DR Gerard Dyson

Managing Director – Spectur Limited (ASX: SP3)

Wellnex Life (ASX: WNX) Webcast Replay

15th February 2024

Live Investor Briefing

In this session Wellnex Life MD Zack Bozinovski and Non-Executive Chairman Mario Tascone discussed what attracted Mario to Wellnex and where he sees the future of the business;

Speaker

DR Gerard Dyson

Managing Director – Spectur Limited (ASX: SP3)

VP Minerals (VPM) Webcast Replay

14th February 2024

Live Investor Briefing

In this session VP Minerals (VPM) Non-Executive Director Graham Howard discussed VPM’s continued resource inventory targeting high grade critical mineral deposits.

Speaker

DR Gerard Dyson Managing Director – Spectur Limited (ASX: SP3)

Propell Holdings (ASX: PHL) Webcast Replay

Live Investor Briefing

In this session Propell CEO Michael Davidson discussed Propell’s recent progress on the platform, cost base, and establishing a broker network…

Speaker

DR Gerard Dyson

Managing Director – Spectur Limited (ASX: SP3)

5th June 2026

5th November 2026

Propell Investor Briefing – November

7th November 2023

Live Investor Briefing

Propell (ASX: PHL) CEO Michael Davidson discusses how the company is successfully disrupting the banks with its innovative lending model, its exponential growth in its user base and revenues in the past year, and plans to take a significant portion of Australia’s $423 billion SME loan book.

Speaker

Events

Credit Intelligence Investor Briefing – 25 June

25th June 2020

Live Investor Briefing

Credit Intelligence (ASX: CI1) Webcast Replay Credit Intelligence Limited (ASX. CI1) is one of the leading diversified debt-restructuring and personal insolvency management services operating in Hong Kong in the credit funding sector. The company is actively looking to grow its...

Speaker

5G Networks Investor Briefing – 24 June

24th June 2020

Live Investor Briefing

5G Networks (ASX: 5GN) is a licenced telecommunications carrier operating across Australia.

Speaker

Nyrada Investor Briefing – 24 June

24th June 2020

Live Investor Briefing

Nyrada Inc. (ASX: NYR) is a preclinical stage, drug discovery and development company, specialising in novel small molecule drugs to treat cardiovascular, neurological, and inflammatory diseases.

Speaker

Meet The CEOs – 24 June

24th June 2020

Live Investor Briefing

Meet the CEOs Webcast Replay This week join 3 CEOs of exciting ASX listed businesses, they will be giving valuable insight to their industries and companies future prospects. James Bonnar from Nyrada Inc. (ASX.NYR) Joe Demase from 5G Networks (ASX.5GN)...

Speaker

K-Tig Welding Investor Briefing – 24 June

24th June 2020

Live Investor Briefing

K-TIG (ASX: KTG) is the developer and manufacturer of a patented, high productivity welding technology known as Keyhole TIG.

Speaker

Global Dispersion Investment – 19 June

19th June 2020

Live Investor Briefing

Global Dispersion Investment Webcast Replay An investment designed to perform with increased market uncertainty. Learn how you can benefit from future volatility caused economic or geo-political events and this opportunity is being used by some as a hedge against market...

Speaker

Meet The CEOs – 17 June

17th June 2020

Live Investor Briefing

Meet the CEOs Webcast Replay This week join 3 CEOs of exciting ASX listed businesses, they will be giving valuable insight to their industries and companies future prospects. Jimmie Wong, from Credit Intelligence Ltd (ASX.CI1) Michael Johnson, from Rhinomed (ASX.RNO)...

Speaker

Novonix Limited Investor Briefing – 17 June

17th June 2020

Live Investor Briefing

Novonix Limited (ASX.NVX) is an integrated developer and supplier of high-performance materials, equipment and services for the global lithium-ion battery industry with operations in the USA and Canada and sales in more than 14 countries.

Speaker

Rhinomed Investor Briefing – 17 June

17th June 2020

Live Investor Briefing

Rhinomed Limited (ASX.RNO) is a Melbourne based ASX listed airway technology company that has developed a simple and innovative nasal stent to improve air flow to the lungs and deliver therapeutic agents.

Speaker

Credit Intelligence Investor Briefing – 17 June

17th June 2020

Live Investor Briefing

Credit Intelligence Limited (ASX. CI1) is one of the leading diversified debt-restructuring and personal insolvency management services operating in Hong Kong in the credit funding sector.

Speaker

Meet The CEOs – 10 June

10th June 2020

Live Investor Briefing

Meet the CEOs Webcast Replay This week join 3 CEOs of exciting ASX listed businesses, they will be giving valuable insight to their industries and companies future prospects. Dennis Karp, from Manuka Resources Sol Lukatsky, from Spirit Telecom (ST1.ASX) Matthew...

Speaker

NeuroScienfitic Biopharmaceuticals Investor Briefing – 10 June

10th June 2020

Live Investor Briefing

NeuroScienfitic Biopharmaceuticals Ltd (ASX: NSB) is a drug development company focused on developing novel peptide-based pharmaceutical drugs for the treatment of neurodegenerative conditions with high unmet medical need.

Speaker

We prioritise transparency in everything we do; our primary objectives are your satisfaction and success.

Send me information on new events as they become available

By clicking submit, I agree to the terms of the Reach Markets Financial Services Guide that includes the Privacy Statement.



Speak to the Reach Markets team




What is a 708 investor?

By clicking submit, I agree to the terms of the Reach Markets Financial Services Guide that includes the Privacy Statement.